{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:16:38Z","timestamp":1792790198119,"version":"4.5.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100015359","name":"Institute for the Brain and Cognitive Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009155","name":"Otsuka America Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009155","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Connecticut Research Foundation","id":[{"id":"https:\/\/ror.org\/02der9h97","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cogn Affect Behav Neurosci"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.3758\/s13415-025-01344-7","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:59:50Z","timestamp":1758740390000},"page":"558-572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dopamine antagonist effects of the D2\/D3 receptor partial agonist aripiprazole on effort-based choice tasks in male and female rats"],"prefix":"10.3758","volume":"26","author":[{"given":"Gayle A.","family":"Edelstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alev","family":"Ecevitoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Mitola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Goldhamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Beard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aastha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Vaidian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Rochette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Martinez-Verdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regulo","family":"Olivares-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Matas-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merce","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Salamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"issue":"2","key":"1344_CR1","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/s0306-4522(99)00004-4","volume":"92","author":"JE Aberman","year":"1999","unstructured":"Aberman, J. E., & Salamone, J. D. (1999). Nucleus accumbens dopamine depletions make rats more sensitive to high ratio requirements but do not impair primary food reinforcement. Neuroscience, 92(2), 545\u2013552. https:\/\/doi.org\/10.1016\/s0306-4522(99)00004-4","journal-title":"Neuroscience"},{"key":"1344_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1037\/a0036299","volume":"123","author":"DM Barch","year":"2014","unstructured":"Barch, D. M., Treadway, M. T., & Schoen, N. (2014). Effort, anhedonia, and function in schizophrenia: Reduced effort allocation predicts amotivation and functional impairment. Journal of Abnormal Psychology, 123, 387\u2013397.","journal-title":"Journal of Abnormal Psychology"},{"issue":"6","key":"1344_CR3","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/JCP.0000000000000577","volume":"36","author":"C Blemonte","year":"2016","unstructured":"Blemonte, C., Ochoa, D., Rom\u00e1n, M., Cabaleiro, T., Taleg\u00f3n, M., S\u00e1nchez-Rojas, S. D., & Abad-Santos, F. (2016). Evaluation of the relationship between pharmacokinetics and the safety of aripiprazole and its cardiovascular effects in healthy volunteers. Journal of Clinical Psychopharmacology, 36(6), 608\u2013614.","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"1344_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bcp.2014.10.014","volume":"93","author":"T Brust","year":"2015","unstructured":"Brust, T., Hayes, M., Roman, D., & Watts, V. (2015). New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated G\u03b2\u03b3 signaling. Biochemical Pharmacology, 93(1), 85\u201391.","journal-title":"Biochemical Pharmacology"},{"issue":"4","key":"1344_CR5","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S1734-1140(11)70605-3","volume":"63","author":"K Burda","year":"2011","unstructured":"Burda, K., Czubak, A., Kus, K., Nowakowska, E., Ratajczak, P., & Zin, J. (2011). Influence of aripiprazole on the antidepressant, anxiolytic and cognitive functions of rats. Pharmacological Reports, 63(4), 898\u2013907.","journal-title":"Pharmacological Reports"},{"key":"1344_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1124\/jpet.102.033175","volume":"302","author":"KD Burris","year":"2002","unstructured":"Burris, K. D., Molski, T. F., Xu, C., Ryan, E., Tottori, K., Kikuchi, T., Yocca, F. D., & Molinoff, P. B. (2002). Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. The Journal of Pharmacology and Experimental Therapeutics, 302, 381\u2013389.","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"1344_CR7","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00213-023-06412-9","volume":"240","author":"C Carratal\u00e1-Ros","year":"2023","unstructured":"Carratal\u00e1-Ros, C., Mart\u00ednez-Verd\u00fa, A., Olivares-Garc\u00eda, R., Salamone, J. D., & Correa, M. (2023). Effects of the dopamine depleting agent tetrabenazine in tests evaluating different components of depressive-like behavior in mice: Sex-dependent response to antidepressant drugs with SERT and DAT blocker profiles. Psychopharmacology, 240, 1615\u20131628.","journal-title":"Psychopharmacology"},{"key":"1344_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cortex.2015.04.003","volume":"69","author":"TT Chong","year":"2015","unstructured":"Chong, T. T., Bonnelle, V., Manohar, S., Veromann, K. R., Muhammed, K., Tofaris, G. K., Hu, M., & Husain, M. (2015). Dopamine enhances willingness to exert effort for reward in Parkinson\u2019s disease. Cortex, 69, 40\u201346.","journal-title":"Cortex"},{"key":"1344_CR9","doi-asserted-by":"crossref","unstructured":"Correa, M., Carlson, B. B., Wisniecki, & Salamone, J. D. (2002). Nucleus accumbens dopamine and work requirements on interval schedule. Behavioral Brain Research, 137(1-2), 179-187.","DOI":"10.1016\/S0166-4328(02)00292-9"},{"issue":"4","key":"1344_CR10","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/0091-3057(93)90226-j","volume":"46","author":"MS Cousins","year":"1993","unstructured":"Cousins, M. S., Sokolowski, J. D., & Salamone, J. D. (1993). Different effects of nucleus accumbens and ventrolateral striatal dopamine depletions on instrumental response selection in the rat. Pharmacology, Biochemistry and Behavior, 46(4), 943\u2013951. https:\/\/doi.org\/10.1016\/0091-3057(93)90226-j","journal-title":"Pharmacology, Biochemistry and Behavior"},{"issue":"1\u20132","key":"1344_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0166-4328(95)00151-4","volume":"74","author":"MS Cousins","year":"1996","unstructured":"Cousins, M. S., Atherton, A., Turner, L., & Salamone, J. D. (1996). Nucleus accumbens dopamine depletions alter relative response allocation in a T-maze cost\/benefit task. Behavioural Brain Research, 74(1\u20132), 189\u2013197.","journal-title":"Behavioural Brain Research"},{"issue":"7","key":"1344_CR12","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/jcph.2026","volume":"62","author":"C Crapanzano","year":"2022","unstructured":"Crapanzano, C., Laurenzi, P. F., Amendola, C., & Casolaro, I. (2022). Combining aripiprazole and haloperidol: Focus on D2 receptor. The Journal of Clinical Pharmacology, 62(7), 918\u2013918.","journal-title":"The Journal of Clinical Pharmacology"},{"key":"1344_CR13","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/sj.npp.1300603","volume":"30","author":"P Dazzan","year":"2005","unstructured":"Dazzan, P., Morgan, K. D., Orr, K., Hutchinson, G., Chitnis, X., Suckling, J., Fearon, P., McGuire, P. K., Mallett, R. M., Jones, P. B., Leff, J., & Murray, R. M. (2005). Different effects of typical and atypical antipsychotics on grey matter in first episode of psychosis: The AESOP study. Neuropsychopharmacology, 30, 765\u2013744.","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"1344_CR14","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s40263-015-0278-3","volume":"29","author":"A de Bartolomeis","year":"2015","unstructured":"de Bartolomeis, A., Tomasetti, C., & Iasevoli, F. (2015). Update on the mechanism of action of aripiprazole: Translational insights into antipsychotic strategies beyond dopamine receptor antagonism. CNS Drugs, 29(9), 773\u2013799.","journal-title":"CNS Drugs"},{"issue":"2","key":"1344_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/0304-3940(88)90758-6","volume":"91","author":"J De Keyser","year":"1988","unstructured":"De Keyser, J., Claeys, A., De Backer, J. P., Ebinger, G., Roels, F., & Vauquelin, G. (1988). Autoradiographic localization of D1 and D2 dopamine receptors in the human brain. Neursocience Letters, 91(2), 142\u2013147.","journal-title":"Neursocience Letters"},{"issue":"8","key":"1344_CR16","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s00213-023-06405-8","volume":"240","author":"A Ecevitoglu","year":"2023","unstructured":"Ecevitoglu, A., Edelstein, G. A., Presby, R. E., Rotolo, R. A., Yang, J. H., Quiles, T., Okifo, K., Conrad, R. T., Kovach, A., Correa, M., & Salamone, J. D. (2023). Effects of the atypical antipsychotic and D3\/D2 dopamine partial agonist cariprazine on effort-based choice behavior: Implications for modeling avolition. Psychopharmacology, 240(8), 1747\u20131757. https:\/\/doi.org\/10.1007\/s00213-023-06405-8","journal-title":"Psychopharmacology"},{"issue":"10","key":"1344_CR17","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1007\/s00213-024-06615-8","volume":"241","author":"A Ecevitoglu","year":"2024","unstructured":"Ecevitoglu, A., Beard, R. K., Srynath, S., Edelstein, G. A., Olivares-Garcia, R., Martinez-Verdu, A., Meka, N., Correa, M., & Salamone, J. D. (2024a). Pharmacological characterization of sex differences in the effects of dopaminergic drugs on effort-based decision making in rats. Psychopharmacology, 241(10), 2033\u20132044. https:\/\/doi.org\/10.1007\/s00213-024-06615-8","journal-title":"Psychopharmacology"},{"issue":"8","key":"1344_CR18","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/s41386-024-01826-1","volume":"49","author":"A Ecevitoglu","year":"2025","unstructured":"Ecevitoglu, A., Meka, N., Rotolo, R. A., Edelstein, G. A., Srinath, S., Beard, K. R., Carratla-Ros, C., Presby, R. E., Cao, J., Okorom, A., Newman, A. H., Correa, M., & Salamone, J. D. (2024b). Potential therapeutics for effort-related motivational dysfunction: Assessing novel atypical dopamine transport inhibitors. Neuropsychopharmacology, 49(8), 1309\u20131317. https:\/\/doi.org\/10.1038\/s41386-024-01826-1","journal-title":"Neuropsychopharmacology"},{"key":"1344_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2025.110345","volume":"269","author":"A Ecevitoglu","year":"2025","unstructured":"Ecevitoglu, A., Rotolo, R. A., Edelstein, G. A., Goldhamer, A., Mitola, M., Presby, R. E., Yu, A., Pietrorazio, D., Zorda, E., Correa, M., & Salamone, J. D. (2025). Effort-related motivational effects of methylphenidate: Reversal of the low-effort bias induced by tetrabenazine and enhancement of progressive ratio responding in male and female rats. Neuropharmacology, 269, Article 110345. https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110345","journal-title":"Neuropharmacology"},{"issue":"6","key":"1344_CR20","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s00213-021-05795-x","volume":"238","author":"EL Errante","year":"2021","unstructured":"Errante, E. L., Chakkalamuri, M., Akinbo, O. I., Yohn, S. E., Salamone, J. D., & Matuszewich, L. (2021). Sex differences in effort-related decision-making: Role of dopamine D2 receptor antagonism. Psychopharmacology, 238(6), 1609\u20131619.","journal-title":"Psychopharmacology"},{"issue":"4","key":"1344_CR21","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.neuroscience.2009.12.056","volume":"166","author":"AM Farrar","year":"2010","unstructured":"Farrar, A. M., Segovia, K. N., Randall, P. A., Nunes, E. J., Collins, L. E., Stopper, C. M., Port, R. G., Hockemeyer, J., M\u00fcller, C. E., Correa, M., & Salamone, J. D. (2010). Nucleus accumbens and effort-related functions: Behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors. Neuroscience, 166(4), 1056\u20131067. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.12.056","journal-title":"Neuroscience"},{"issue":"12","key":"1344_CR22","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1517\/14656566.6.12.2091","volume":"6","author":"W Fleischhacker","year":"2005","unstructured":"Fleischhacker, W. (2005). Aripiprazole. Expert Opinion on Pharmacotherpay, 6(12), 2091\u20132101.","journal-title":"Aripiprazole. Expert Opinion on Pharmacotherpay"},{"key":"1344_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-psych-010213-115159","volume":"66","author":"SB Floresco","year":"2015","unstructured":"Floresco, S. B. (2015). The nucleus accumbens: An interface between cognition, emotion, and action. Annual Review Psychology, 66, 25\u201352.","journal-title":"Annual Review Psychology"},{"issue":"8","key":"1344_CR24","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1038\/sj.npp.1301565","volume":"33","author":"SB Floresco","year":"2008","unstructured":"Floresco, S. B., Tse, M. T., & Ghods-Sharifi, S. (2008). Dopaminergic and glutamatergic regulation of effort- and delay-based decision making. Neuropsychopharmacology, 33(8), 1966\u20131979. https:\/\/doi.org\/10.1038\/sj.npp.1301565","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"1344_CR25","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/0091-3057(94)90228-3","volume":"49","author":"SC Fowler","year":"1994","unstructured":"Fowler, S. C., & Das, S. (1994). Haloperidol-induced decrements in force and duration of rats\u2019 tongue movements during licking are attenuated by concomitant anticholinergic treatment. Pharmacology, Biochemistry and Behavior, 49(4), 813\u2013817.","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"1344_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/mds.21240","volume":"22","author":"JH Friedman","year":"2007","unstructured":"Friedman, J. H., Brown, R. G., Comella, C., Garber, C. E., Krupp, L. B., Lou, J. S., Marsh, L., Nail, L., Shulman, L., & Taylor, C. B. (2007). Fatigue in Parkinson\u2019s disease: A review. Movement Disorders, 22, 297\u2013308.","journal-title":"Movement Disorders"},{"key":"1344_CR27","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/schbul\/sbv071","volume":"41","author":"MF Green","year":"2015","unstructured":"Green, M. F., Horan, W. P., Barch, D. M., & Gold, J. M. (2015). Effort-based decision-making: A novel approach for assessing motivation in schizophrenia. Schizophrenia Bulletin, 41, 1035\u20131044.","journal-title":"Schizophrenia Bulletin"},{"issue":"3","key":"1344_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.pharmthera.2009.03.002","volume":"122","author":"S Grimwood","year":"2009","unstructured":"Grimwood, S., & Hartig, P. R. (2009). Target site occupancy: Emerging generalizations from clinical and preclinical studies. Pharmacology & Therapeutics, 122(3), 281\u2013301.","journal-title":"Pharmacology & Therapeutics"},{"key":"1344_CR29","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1055\/s-2006-931485","volume":"3","author":"G Grunder","year":"2006","unstructured":"Grunder, G., Kungel, M., Ebrecht, M., Gorocs, T., & Modell, S. (2006). Aripiprazole: Pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia. Pharmacopsychiatry, 3, S21\u2013S25.","journal-title":"Pharmacopsychiatry"},{"key":"1344_CR30","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.neuint.2011.07.002","volume":"59","author":"I Gyerty\u00e1n","year":"2011","unstructured":"Gyerty\u00e1n, I., Kiss, B., S\u00e1ghy, K., Laszy, J., Szab\u00f3, G., Szabados, T., G\u00e9mesi, L. I., P\u00e1sztor, G., Z\u00e1jer-Bal\u00e1zs, M., Kap\u00e1s, M., Csongor, E. A., Dom\u00e1any, G., Tihanyi, K., & Szombathelyi, Z. ((2011)). Cariprazine (RGH-188), a potent D3\/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and precognitive effects in rodents. Neurochemistry International, 59, 925\u2013935.","journal-title":"Neurochemistry International"},{"key":"1344_CR31","doi-asserted-by":"crossref","unstructured":"Hasbi, A., Nguyen, T., Rahal, H., Manduca, J. D., Miksys, S., Tyndale, R. F., Madras, B. K., Perreault, M. L., & George, S. R. (2020). Sex differences in dopamine D1-D2 receptor complex expression and signaling affects depression- and anxiety-like behaviors. Biology of Sex Differences, 11(8).","DOI":"10.1186\/s13293-020-00285-9"},{"key":"1344_CR32","volume-title":"Design and analysis a researcher\u2019s handbook","author":"G Keppel","year":"1991","unstructured":"Keppel, G. (1991). Design and analysis a researcher\u2019s handbook (3rd ed.). Prentice Hall.","edition":"3"},{"issue":"1","key":"1344_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0022-3565(25)10600-9","volume":"27","author":"T Kikuchi","year":"1995","unstructured":"Kikuchi, T., Tottori, K., Uwahodo, Y., Hirose, T., Miwa, T., Oshiro, Y., & Morita, S. (1995). 7-{4-[4-(2,3-Dichlorophenyl)-1-Piperazinyl]butyloxy}-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity. The Journal of Pharmacology and Experimental Therapeutics, 27(1), 329\u2013336.","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"1344_CR34","doi-asserted-by":"crossref","unstructured":"Kiss, B., Horv\u00e1th, A., N\u00e9methy, Z., Schmidt, E., Laszlovsky, I., Bugovics, G., Fazekas, K., Hornok, K., Orosz, S., Gyerty\u00e1n, I., \u00c1gai-Csongor, \u00c9., Dom\u00e1ny, G., Tihanyi, K., Adham, N., & Szombathe, Z. (2010). Cariprazine (RGH-188), a dopamine D3 receptor-preferring, D3\/D2 dopamine receptor antagonist-partial agonist antipsychotic candidate: In vitro and neurochemical profile. The Journal of Pharmacology and Experimental Therapeutics, 333(1).","DOI":"10.1124\/jpet.109.160432"},{"key":"1344_CR35","doi-asserted-by":"crossref","unstructured":"Lawler, C., Prioleau, C., Lewis, M., Mark, C., Jiang, D., Schetz, J., Gonzalez, A., Sibley, D., & Mailman, R. (1999). Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology, 20(6).","DOI":"10.1016\/S0893-133X(98)00099-2"},{"issue":"4","key":"1344_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ijnp\/pyu046","volume":"18","author":"GF Ma","year":"2015","unstructured":"Ma, G. F., Raivio, N., Sabria, J., & Ortiz, J. (2015). Agonist and antagonist effects of aripiprazole on D2-like receptors controlling rat brain dopamine synthesis depend on the dopaminergic tone. International Journal of Neuropsychopharmacology, 18(4), 1\u20139.","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"3","key":"1344_CR37","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1124\/jpet.114.213819","volume":"350","author":"K Maeda","year":"2014","unstructured":"Maeda, K., Lerdrup, L., Sugino, H., Akazawa, H., Amada, N., McQuade, R. D., Stensb\u00f8l, T. B., Bundgaard, C., Arnt, J., & Kikuchi, T. (2014). Brexpiprazole II: Antipsychotic-like and precognitive effects of a novel serotonin-dopamine activity modulator. Journal of Pharmacology and Experimental Therapeutics, 350(3), 605\u2013614.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"1344_CR38","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2174\/138161210790361461","volume":"16","author":"RB Mailman","year":"2010","unstructured":"Mailman, R. B., & Murthy, V. (2010). Third generation antipsychotic drugs: Partial agonism or receptor functional selectivity. Current Pharmaceutical Design, 16, 488\u2013501.","journal-title":"Current Pharmaceutical Design"},{"key":"1344_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-023-01646-9","author":"I Maita","year":"2023","unstructured":"Maita, I., Bazer, A., Chae, K., Parida, A., Mirza, M., Sucher, J., Phan, M., Liu, T., Hu, P., Soni, R., Roepke, T. A., & Samuels, B. A. (2023). Chemogenetic activation of corticotropin-releasing factor-expressing neurons in the anterior bed nucleus of the stria terminalis reduces effortful motivation behaviors. Neuropsychopharmacology. https:\/\/doi.org\/10.1038\/s41386-023-01646-9","journal-title":"Neuropsychopharmacology"},{"key":"1344_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60010046","author":"V Mani","year":"2023","unstructured":"Mani, V., & Alshammeri, B. S. (2023). Aripiprazole attenuates cognitive impairments induced by lipopolysaccharide in rats through the regulation of neuronal inflammation, oxidative stress, and apoptosis. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina60010046","journal-title":"Medicina (Kaunas)"},{"issue":"11","key":"1344_CR41","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s00213-023-06430-7","volume":"240","author":"P Matas-Navarro","year":"2023","unstructured":"Matas-Navarro, P., Carratal\u00e1-Ros, C., Olivares-Garc\u00eda, R., Mart\u00ednez-Verd\u00fa, A., Salamone, J., & Correa, M. (2023). Sex and age differences in mice models of effort-based decision-making and anergia in depression: The role of dopamine, and cerebral-dopamine-neurotrophic-factor. Psychopharmacology, 240(11), 2285\u20132302.","journal-title":"Psychopharmacology"},{"key":"1344_CR42","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/S0026-895X(25)10474-4","volume":"31","author":"E Meller","year":"1987","unstructured":"Meller, E., Bohmaker, K., Namba, Y., Friedhoff, A. J., & Goldstein, M. (1987). Relationship between receptor occupancy and response at striatal dopamine autoreceptors. Molecular Pharmacology, 31, 592\u2013598.","journal-title":"Molecular Pharmacology"},{"key":"1344_CR43","doi-asserted-by":"crossref","unstructured":"Mohr, P., Masopust, H., & Koecek, M. (2022). Dopamine receptor partial agonists: Do they differ in their clinical efficacy? Frontiers in Psychiatry, 12.","DOI":"10.3389\/fpsyt.2021.781946"},{"issue":"1\u20132","key":"1344_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0014-2999(03)01857-0","volume":"472","author":"S Nakai","year":"2003","unstructured":"Nakai, S., Hirose, T., Uwahodo, Y., Imaoka, T., Okazaki, H., Miwa, T., Nakai, M., Yamada, S., Dunn, B., Burris, K., Molinoff, P., Tottori, K., Altar, C., & Kikuchi, T. (2003). Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone. European Journal of Pharmacology, 472(1\u20132), 89\u201397.","journal-title":"European Journal of Pharmacology"},{"issue":"3\u20134","key":"1344_CR45","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/s0091-3057(01)00524-x","volume":"69","author":"KL Nowend","year":"2001","unstructured":"Nowend, K. L., Arizzi, M., Carlson, B. B., & Salamone, J. D. (2001). D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption. Pharmacology, Biochemistry and Behavior, 69(3\u20134), 373\u2013382. https:\/\/doi.org\/10.1016\/s0091-3057(01)00524-x","journal-title":"Pharmacology, Biochemistry and Behavior"},{"issue":"49","key":"1344_CR46","doi-asserted-by":"publisher","first-page":"19120","DOI":"10.1523\/JNEUROSCI.2730-13.2013","volume":"33","author":"EJ Nunes","year":"2013","unstructured":"Nunes, E. J., Randall, P. A., Hart, E. E., Freeland, C., Yohn, S. E., Baqi, Y., M\u00fcller, C. E., L\u00f3pez-Cruz, L., Correa, M., & Salamone, J. D. (2013). Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: Implications for animal models of the motivational symptoms of depression. Journal Of Neuroscience, 33(49), 19120\u201319130. 10. 1523\/JNEUROSCI.2730-13.2013.","journal-title":"Journal Of Neuroscience"},{"issue":"1","key":"1344_CR47","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.neuroscience.2010.05.068","volume":"170","author":"EJ Nunes","year":"2010","unstructured":"Nunes, E. J., Randall, P. A., Santerre, J. L., Given, A. B., Sager, T. N., Correa, M., & Salamone, J. D. (2010). Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism. Neuroscience, 170(1), 268\u2013280. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.05.068","journal-title":"Neuroscience"},{"key":"1344_CR48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neuint.2016.09.001","volume":"100","author":"EN Orendain-Jaime","year":"2016","unstructured":"Orendain-Jaime, E. N., Ortega-Ibarra, J. M., & L\u00f3pez-P\u00e9rez, S. J. (2016). Evidence of sexual dimorphism in D1 and D2 dopaminergic receptors expression in frontal cortex and striatum of young rats. Neurochemistry International, 100, 62\u201366.","journal-title":"Neurochemistry International"},{"key":"1344_CR49","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/11538980-000000000-00000","volume":"25","author":"C-U Pae","year":"2011","unstructured":"Pae, C.-U., Forbes, A., & Patkar, A. A. (2011). Aripiprazole as adjunctive therapy for patients with major depressive disorder. Overview and implications of clinical trial data. CNS Drugs, 25, 109\u2013127.","journal-title":"CNS Drugs"},{"issue":"13","key":"1344_CR50","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1007\/s00213-015-3872-7","volume":"232","author":"M Pardo","year":"2015","unstructured":"Pardo, M., L\u00f3pez-Cruz, L., San Miguel, N., Salamone, J. D., & Correa, M. (2015). Selection of sucrose concentration depends on the effort required to obtain it: Studies using tetrabenazine, D1, D2, and D3 receptor antagonists. Psychopharmacology, 232(13), 2377\u20132391. https:\/\/doi.org\/10.1007\/s00213-015-3872-7","journal-title":"Psychopharmacology"},{"key":"1344_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2021.173115","volume":"202","author":"RE Presby","year":"2021","unstructured":"Presby, R. E., Rotolo, R. A., Hurley, E. M., Ferrigno, S. M., Murphy, C. E., McMullen, H. P., Desai, P. A., Zorda, E. M., Kuperwasser, F. B., Carratala-Ros, C., Correa, M., & Salamone, J. D. (2021). Sex differences in lever pressing and running wheel tasks of effort-based choice behavior in rats: Suppression of high effort activity by the serotonin transport inhibitor fluoxetine. Pharmacology Biochemistry and Behavior, 202, Article 173115. https:\/\/doi.org\/10.1016\/j.pbb.2021.173115","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"6","key":"1344_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099320","volume":"9","author":"PA Randall","year":"2014","unstructured":"Randall, P. A., Lee, C. A., Nunes, E. J., Yohn, S. E., Nowak, V., Khan, B., Shah, P., Pandit, S., Vemuri, V. K., Makriyannis, A., Baqi, Y., M\u00fcller, C. E., Correa, M., & Salamone, J. D. (2014). The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio\/chow feeding choice task: Reversal with antidepressant drugs. PLoS One, 9(6), Article e99320.","journal-title":"PLoS One"},{"issue":"2","key":"1344_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ijnp\/pyu017","volume":"18","author":"PA Randall","year":"2015","unstructured":"Randall, P. A., Lee, C. A., Podurgiel, S. J., Hart, E., Yohn, S. E., Jones, M., Rowland, M., L\u00f3pez-Cruz, L., Correa, M., & Salamone, J. D. (2015). Bupropion increases selection of high effort activity in rats tested on a progressive ratio\/chow feeding choice procedure: Implications for treatment of effort-related motivational symptoms. International Journal of Neuropsychopharmacology, 18(2), 1\u201311.","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"1344_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047934","volume":"7","author":"PA Randall","year":"2012","unstructured":"Randall, P. A., Pardo, M., Nunes, E. J., Lopez Cruz, L., Vemuri, V. K., Makriyannis, A., Baqi, Y., Muller, C. E., Correa, M., & Salamone, J. D. (2012). Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio task: Pharmacological studies and role of individual differences. PLoS One, 7, Article Article e47934.","journal-title":"PLoS One"},{"key":"1344_CR55","unstructured":"Remington, G. (2010). Second and Third Generation Antipsychotics. In: Stolerman, I.P. (eds) Encyclopedia of Psychopharmacology. Springer, Berlin, Heidelberg."},{"issue":"3","key":"1344_CR56","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/jeab.754","volume":"117","author":"N Ren","year":"2022","unstructured":"Ren, N., Carratala-Ros, C., Ecevitoglu, A., Rotolo, R. A., Edelstein, G. A., Presby, R. E., Stevenson, I. H., Chrobak, J. J., & Salamone, J. D. (2022). Effects of the dopamine depleting agent tetrabenazine on detailed temporal parameters of effort-related choice responding. Journal of the Experimental Analysis of Behavior, 117(3), 331\u2013345. https:\/\/doi.org\/10.1002\/jeab.754","journal-title":"Journal of the Experimental Analysis of Behavior"},{"key":"1344_CR57","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0014-2999(84)90562-4","volume":"102","author":"DJ Pettibone","year":"1984","unstructured":"Pettibone, D. J., Totaro, J. A., & Pfueger, A. B. (1984). Tetrabenazine-induced depletion of brain monoamines: Characterization and interaction with selected antidepressants. European Journal of Pharmacology, 102, 425\u2013430. https:\/\/doi.org\/10.1016\/0014-2999(84)90562-4","journal-title":"European Journal of Pharmacology"},{"key":"1344_CR58","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3389\/fphar.2019.00682","volume":"10","author":"RA Rotolo","year":"2019","unstructured":"Rotolo, R. A., Dragacevic, V., Kalaba, P., Urban, K., Zehl, M., Roller, A., Wackerlig, J., Langer, T., Pistis, M., De Luca, M. A., Caria, F., Schwartz, R., Presby, R. E., Yang, J. H., Samels, S., Correa, M., Lubec, G., & Salamone, J. D. (2019). The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding. Frontiers in Pharmacology, 10, 682.","journal-title":"Frontiers in Pharmacology"},{"issue":"11","key":"1344_CR59","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1007\/s00213-020-05625-6","volume":"237","author":"RA Rotolo","year":"2020","unstructured":"Rotolo, R. A., Kalaba, P., Dragacevic, V., Presby, R. E., Neri, J., Robertson, E., Yang, J. H., Correa, M., Bakulev, V., Volkova, N. N., Pifl, C., Lubec, G., & Salamone, J. D. (2020). Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: Reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding. Psychopharmacology, 237(11), 3459\u20133470.","journal-title":"Psychopharmacology"},{"key":"1344_CR60","doi-asserted-by":"crossref","unstructured":"Rotolo, R. A., Presby, R. E., Tracey, O., Asar, S., Yang, J-H., Correa, M., Murray, F., & Salamone, J. D. (2021). The novel atypical dopamine transport inhibitor CT-005404 reverses the effort-related motivational effects of tetrabenazine and Interleukin-1\u03b2 and increases progressive ratio responding. Neuropharmacology.","DOI":"10.1016\/j.neuropharm.2020.108325"},{"issue":"1","key":"1344_CR61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1369-1600.2006.00011.x","volume":"11","author":"JD Salamone","year":"2006","unstructured":"Salamone, J. D. (2006). Will the last person who uses the term \u2018reward\u2019 please turn out the light? Comments on processes related to reinforcement, learning, motivation, and effort. Addiction Biology, 11(1), 43\u201344.","journal-title":"Addiction Biology"},{"key":"1344_CR62","doi-asserted-by":"publisher","DOI":"10.25006\/IA.4.S2-A13.13","volume":"4","author":"JD Salamone","year":"2016","unstructured":"Salamone, J. D. (2016). Dopamine, effort and behavioral activation: Animal models of effort-related motivational symptoms in psychopathology. Intrinsic Activity, 4, Article A13.13.","journal-title":"Intrinsic Activity"},{"issue":"4","key":"1344_CR63","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00213-001-0994-x","volume":"160","author":"JD Salamone","year":"2002","unstructured":"Salamone, J. D., Arizzi, M. N., Sandoval, M. D., Cervone, K. M., & Aberman, J. E. (2002). Dopamine antagonists alter response allocation but do not suppress appetite for food in rats: Contrast between the effects of SKF83566, raclopride, and fenfluramine on a concurrent choice task. Psychopharmacology, 160(4), 371\u2013380.","journal-title":"Psychopharmacology"},{"key":"1344_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0166-4328(02)00282-6","volume":"137","author":"JD Salamone","year":"2002","unstructured":"Salamone, J. D., & Correa, M. (2002). Motivational views of reinforcement: Implications for understanding the behavioral functions of nucleus accumbens dopamine. Behavioural Brain Research, 137, 3\u201325.","journal-title":"Behavioural Brain Research"},{"key":"1344_CR65","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.neuron.2012.10.021","volume":"76","author":"JD Salamone","year":"2012","unstructured":"Salamone, J. D., & Correa, M. (2012). The mysterious motivational functions of mesolimbic dopamine. Neuron, 76, 470\u2013485.","journal-title":"Neuron"},{"key":"1344_CR66","first-page":"515","volume":"5","author":"JD Salamone","year":"2022","unstructured":"Salamone, J. D., & Correa, M. (2022). Critical review of RDoC approaches to the study of motivation with animal models: Effort valuation\/willingness to work. Emerging Topics in Life Sciences, 5, 515\u2013528.","journal-title":"Emerging Topics in Life Sciences"},{"key":"1344_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-psych-020223-012208","volume":"75","author":"JD Salamone","year":"2024","unstructured":"Salamone, J. D., & Correa, M. (2024). The neurobiology of activational aspects of motivation: Exertion of effort, effort-based decision making, and the role of dopamine. Annual Review of Psychology, 75, 1\u201332. https:\/\/doi.org\/10.1146\/annurev-psych-020223-012208","journal-title":"Annual Review of Psychology"},{"key":"1344_CR68","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00213-006-0668-9","volume":"191","author":"JD Salamone","year":"2007","unstructured":"Salamone, J. D., Correa, M., Farrar, A., & Mingote, S. M. (2007). Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology, 191, 461\u2013482.","journal-title":"Psychopharmacology"},{"key":"1344_CR69","doi-asserted-by":"crossref","unstructured":"Salamone, J. D., Correa, M., Farrar, A. M., Nunes, E. J., & Pardo, M. (2009). Dopamine, behavioral economics, and effort. Frontiers in Behavioral Neuroscience, 3(13).","DOI":"10.3389\/neuro.08.013.2009"},{"key":"1344_CR70","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1901\/jeab.2012.97-125","volume":"97","author":"JD Salamone","year":"2012","unstructured":"Salamone, J. D., Correa, M., Nunes, E. J., Randall, P. A., & Pardo, M. (2012). The behavioral pharmacology of effort-related choice behavior: Dopamine, adenosine, and beyond. Journal of the Experimental Analysis of Behavior, 97, 125\u2013146.","journal-title":"Journal of the Experimental Analysis of Behavior"},{"key":"1344_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2018.00052","author":"JD Salamone","year":"2018","unstructured":"Salamone, J. D., Correa, M., Yang, J. H., Rotolo, R., & Presby, R. (2018). Dopamine, effort-based choice, and behavioral economics: Basic and translational research. Frontiers in Behavioral Neuroscience. https:\/\/doi.org\/10.3389\/fnbeh.2018.00052","journal-title":"Frontiers in Behavioral Neuroscience"},{"key":"1344_CR72","doi-asserted-by":"publisher","unstructured":"Salamone, J. D., Correa, M., Yohn, S., Cruz, L. L., Miguel, N. S., & Alatorre, L. (2016a). The pharmacology of effort-related choice behavior: Dopamine, depression, and individual differences. Behavioural Processes. https:\/\/doi.org\/10.1016\/j.beproc.2016.02.008","DOI":"10.1016\/j.beproc.2016.02.008"},{"key":"1344_CR73","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainresbull.2022.01.019","volume":"182","author":"JD Salamone","year":"2022","unstructured":"Salamone, J. D., Ecevitoglu, A., Carratala-Ros, C., Presby, R. E., Edelstein, G. A., Fleeher, R., Rotolo, R. A., Meka, N., Srinath, S., Masthay, J. C., & Correa, M. (2022). Complexities and paradoxes in understanding the role of dopamine in incentive motivation and instrumental action: Exertion of effort vs. anhedonia. Brain Research Bulletin, 182, 57\u201366. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.01.019","journal-title":"Brain Research Bulletin"},{"key":"1344_CR74","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/BF02245659","volume":"104","author":"JD Salamone","year":"1991","unstructured":"Salamone, J. D., Steinpreis, R. E., McCullough, L. D., Smith, P., Grebel, D., & Mahan, K. (1991). Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology, 104, 515\u2013521.","journal-title":"Psychopharmacology"},{"key":"1344_CR75","unstructured":"Salamone, J. D., Srynath, S., Evevitoglu, A., Edelstein, G. A., Meka, N., Pietrorazio, D., Dwy, C. J., & Correa, M. (2022b). Exploring possible sex differences in the effort-related motivational effects of dopamine antagonists and dopamine depletion with tetrabenazine. Program No. 730.01. 2022b Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience, 2022. Online."},{"key":"1344_CR76","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/brain\/aww050","volume":"139","author":"JD Salamone","year":"2016","unstructured":"Salamone, J. D., Yohn, S. E., Lopez-Cruz, L., San Miguel, N., & Correa, M. (2016). Activational and effort-related aspects of motivation: Neural mechanisms and implications for psychopathology. Brain, 139, 1325\u20131347.","journal-title":"Brain"},{"issue":"4","key":"1344_CR77","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.pbb.2012.06.009","volume":"102","author":"JL Santerre","year":"2012","unstructured":"Santerre, J. L., Nunes, E. J., Kovner, R., Leser, C. E., Randall, P. A., Collins-Praino, L. E., Lopez Cruz, L., Correa, M., Baqi, Y., M\u00fcller, C. E., & Salamone, J. D. (2012). The novel adenosine A(2A) antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions. Pharmacology, Biochemistry and Behavior, 102(4), 477\u2013487. https:\/\/doi.org\/10.1016\/j.pbb.2012.06.009","journal-title":"Pharmacology, Biochemistry and Behavior"},{"issue":"7","key":"1344_CR78","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/0028-3908(95)00059-F","volume":"34","author":"J Semba","year":"1995","unstructured":"Semba, J., Watanabe, A., Kito, S., & Toru, M. (1995). Behavioural and neurochemical effects of OPC-14597, a novel antipsychotic drug, on dopaminergic mechanisms in rat brain. Neuropharmacology, 34(7), 785\u2013791.","journal-title":"Neuropharmacology"},{"key":"1344_CR79","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jad.2017.10.032","volume":"227","author":"S Scheggi","year":"2018","unstructured":"Scheggi, S., Pellicca, T., Gambarana, C., & De Montis, M. G. (2018). Aripiprazole relieves motivational anhedonia in rats. Journal of Affective Disorders, 227, 192\u2013197.","journal-title":"Journal of Affective Disorders"},{"key":"1344_CR80","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00213-006-0520-2","volume":"191","author":"K Schwabe","year":"2007","unstructured":"Schwabe, K., & Koch, M. (2007). Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats. Psychopharmacology, 191, 759\u2013765.","journal-title":"Psychopharmacology"},{"key":"1344_CR81","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","volume":"28","author":"DA Shapiro","year":"2003","unstructured":"Shapiro, D. A., Renock, S., Arrington, E., Chiodo, L. A., Liu, L.-X., Sibley, D. R., Roth, B. L., & Mailman, R. (2003). Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology, 28, 1400\u20131411.","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"1344_CR82","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00213-007-0988-4","volume":"196","author":"KS Sink","year":"2008","unstructured":"Sink, K. S., Vemuri, V. K., Olszewska, T., Makriyannis, A., & Salamone, J. D. (2008). Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior. Psychopharmacology, 196(4), 565\u2013574.","journal-title":"Psychopharmacology"},{"issue":"12","key":"1344_CR83","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1017\/S1461145714000996","volume":"17","author":"S Sommer","year":"2014","unstructured":"Sommer, S., Danysz, W., Russ, H., Valastro, B., Flik, G., & Hauber, W. (2014). The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats. International Journal of Neuropsychopharmacology, 17(12), 2045\u20132056.","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"1\u20133","key":"1344_CR84","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejphar.2009.02.007","volume":"607","author":"Y Tadori","year":"2009","unstructured":"Tadori, Y., Forbes, R., McQuade, R., & Kikuchi, T. (2009). Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors. European Journal of Pharmacology, 607(1\u20133), 35\u201340.","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"1344_CR85","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.neuropharm.2011.08.031","volume":"62","author":"S Tanahashi","year":"2012","unstructured":"Tanahashi, S., Yamamura, S., Nakagawa, M., Motomura, E., & Okada, M. (2012). Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission. Neuropharmacology, 62(2), 765\u2013774. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.08.031","journal-title":"Neuropharmacology"},{"key":"1344_CR86","doi-asserted-by":"publisher","unstructured":"Treadway, M. T., Bossaller, N. A., Shelton, R. C., & Zald, D. H. (2012). Effort-based decision-making in major depressive disorder: A translational model of motivational anhedonia. Journal of abnormal psychology, 121(3), 553\u2013558. https:\/\/doi.org\/10.1037\/a0028813","DOI":"10.1037\/a0028813"},{"key":"1344_CR87","doi-asserted-by":"crossref","unstructured":"Tuplin, E., & Holahan, M. (2017). Aripiprazole, a drug that displays partial agonism and functional selectivity. Current Neuropharmacology, 15(8).","DOI":"10.2174\/1570159X15666170413115754"},{"issue":"9","key":"1344_CR88","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3390\/brainsci11091199","volume":"11","author":"OOF Williams","year":"2021","unstructured":"Williams, O. O. F., Coppolino, M., George, S. R., & Perreault, M. L. (2021). Sex differences in dopamine receptors and relevance to neuropsychiatric disorders. Brain Sciences, 11(9), 1199.","journal-title":"Brain Sciences"},{"key":"1344_CR89","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/npp.2015.188","volume":"41","author":"SE Yohn","year":"2016","unstructured":"Yohn, S. E., Collins, S. L., Contreras-Mora, H. M., Errante, E. L., Rowland, M. S., Correa, M., & Salamone, J. D. (2016). Not all antidepressants are created equal: Differential effects of monoamine uptake inhibitors on effort-related choice behavior. Neuropsychopharmacology, 41, 686\u2013694.","journal-title":"Neuropsychopharmacology"},{"key":"1344_CR90","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neuropharm.2016.06.018","volume":"109","author":"SE Yohn","year":"2016","unstructured":"Yohn, S. E., Errante, E. L., Rosenbloom-Snow, A., Sommerville, M., Rowland, M. A., Tokarski, K., Zafar, N., Correa, M., & Salamone, J. D. (2016). Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: Implications for treatment of effort-related motivational symptoms in psychopathology. Neuropharmacology, 109, 270\u2013280.","journal-title":"Neuropharmacology"},{"key":"1344_CR91","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.pbb.2015.05.003","volume":"135","author":"SE Yohn","year":"2015","unstructured":"Yohn, S. E., Santerre, J. L., Nunes, E. J., Kozak, R., Podurgiel, S. J., Correa, M., & Salamone, J. D. (2015). The role of dopamine D1 receptor transmission in effort-related choice behavior: Effects of D1 agonists. Pharmacology Biochemistry and Behavior, 135, 217\u2013226. https:\/\/doi.org\/10.1016\/j.pbb.2015.05.003","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"7","key":"1344_CR92","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00213-014-3766-0","volume":"232","author":"SE Yohn","year":"2015","unstructured":"Yohn, S. E., Thompson, C., Randall, P. A., Lee, C. A., M\u00fcller, C. E., Baqi, Y., Correa, M., & Salamone, J. D. (2015). The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: Reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion. Psychopharmacology, 232(7), 1313\u20131323. https:\/\/doi.org\/10.1007\/s00213-014-3766-0","journal-title":"Psychopharmacology"}],"container-title":["Cognitive, Affective, & Behavioral Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.3758\/s13415-025-01344-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.3758\/s13415-025-01344-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.3758\/s13415-025-01344-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:02:21Z","timestamp":1790208141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.3758\/s13415-025-01344-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.3758\/s13415-025-01344-7","relation":{},"ISSN":["1530-7026","1531-135X"],"issn-type":[{"value":"1530-7026","type":"print"},{"value":"1531-135X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was supported by grants to J.S. from Otsuka Pharmaceutical and the University of Connecticut Research Foundation, and to G.E. from the Connecticut Institute for Brain and Cognitive Sciences. J.S. has received grants from and done consulting work for Chronos, Blackthorn, Acadia, Otsuka, and Lundbeck. On behalf of all authors, the corresponding author states that there is no conflict of interest. This research was approved by the Institutional Animal Care and Use Committee of the University of Connecticut. All authors have consented to participate in this research, and have consented to its ultimate publication. Data are stored in a repository at the University of Connecticut and are available on request. Program codes for the behavior experiments are shareable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data are stored on a repository at the University of Connecticut and will be furnished upon request. Data were not preregistered.","order":2,"name":"Ethics","label":"Open practices","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}